Belharra emerges from stealth with $130M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Scripps Spinout Belharra Unveils $130M to Catch Next Big Wave of Drug Discovery Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup's technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bid to targets previously deemed undruggable. Sponsored How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact Presented by Emergn and MedCity News The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: their learning and development (L&D) programs. Learn More

Featured News

Ending Involuntary Commitments Would Shift Burden of Montana's Dementia Care to Strapped Communities A budget estimate attached to proposed legislation in Montana raises questions about whether the state's cash-strapped communities will have the capacity to care for patients with Alzheimer's disease, other types of dementia or traumatic brain injuries by July 2025, when involuntary commitments would cease under the plan. J&J CEO: Our R&D Infrastructure Helps Us Maintain Innovation Amid an Uncertain Economy Johnson & Johnson's CEO believes the company will maintain its strong reputation for innovation amid changing economic conditions because of its hefty investments in research and development. He said it's crucial to invest both internally and externally, as some of the most innovative and lucrative opportunities come from outside companies. Report: MA Performs Better Than Fee-for-service Medicare on Diabetes Care Medicare Advantage patients with diabetes have higher prescription fill rates, fewer emergency department visits and lower total medical spending than traditional fee-for-service Medicare patients, a new report shows. They also received their diagnosis earlier.

Resources

Your Complimentary 2023 HIPAA Checklist Begin 2023 on the right compliance foot. This HIPAA checklist is the best tool to assess your current HIPAA efforts.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe